Editorial: New Insights on Sialic Acid and Sialylated Glycans in the Tumorigenic Process - Takeaways - MDSpire

Editorial: New Insights on Sialic Acid and Sialylated Glycans in the Tumorigenic Process

  • By

  • Rachel A. Willand-Charnley

  • June 9, 2026

  • 0 min

Share

  • 1

    Aberrant glycosylation, particularly changes in sialic acids, is crucial in tumor initiation, progression, and metastasis.

  • 2

    Hypersialylation in tumors is driven by altered expression of glycosylation enzymes, affecting tumor cell behavior.

  • 3

    Sialylated glycans can suppress anti-tumor immune responses by interacting with immune receptors like Siglecs.

  • 4

    Recent advances in glycobiology have enhanced the characterization of tumor-associated glycans and their regulation.

  • 5

    The tumor microenvironment can influence glycan remodeling, with factors promoting hypersialylation in cancer cells.

Original Source(s)

Editorial: New Insights on Sialic Acid and Sialylated Glycans in the Tumorigenic Process

  • by Rachel A. Willand-Charnley

  • June 9, 2026

Related Content

The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics

An exploratory integrative analysis of plasma transcriptomic and proteomic predictors of response to total neoadjuvant therapy in locally advanced rectal cancer

Radiogenomics and the DNA damage response: opportunities for biomarker-guided radiosensitization in pancreatic cancer